drugset / Trial / NCT01683747

Single Dose Enteral Tranexamic Acid in Critically Ill Patients

NCT01683747

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The premise of this study is that enteral tranexamic acid will help to maintain small bowel integrity, which is often compromised by critical illness due to inadequate cardiovascular perfusion (i.e., shock), and that maintenance of small bowel integrity will decrease morbidity in critically ill patients.

Timeline

Start
2012-06
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule Other